{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:21:08Z","timestamp":1793798468408,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240438"],"award-info":[{"award-number":["BK20240438"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300879"],"award-info":[{"award-number":["82300879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116115","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:41:04Z","timestamp":1766767264000},"page":"116115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cryptotanshinone inhibits osteoclast differentiation by targeting LCP1 to suppress diabetic osteoporosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Mingming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41413-022-00198-w","article-title":"Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis","volume":"10","author":"Yang","year":"2022","journal-title":"Bone Res"},{"issue":"6","key":"10.1016\/j.intimp.2025.116115_bb0010","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i6.106720","article-title":"Iron dysregulation, ferroptosis, and oxidative stress in diabetic osteoporosis: mechanisms, bone metabolism disruption, and therapeutic strategies","volume":"16","author":"Wang","year":"2025","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2025.116115_bb0015","doi-asserted-by":"crossref","first-page":"1052592","DOI":"10.3389\/fendo.2022.1052592","article-title":"A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.intimp.2025.116115_bb0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jcb.21573","article-title":"Understanding the pathology and mechanisms of type I diabetic bone loss","volume":"102","author":"McCabe","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"25","key":"10.1016\/j.intimp.2025.116115_bb0025","article-title":"Immunometabolism of macrophages in the bone microenvironment: a new perspective for bone healing therapy","volume":"S2090-1232","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2025.116115_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.753194","article-title":"PPARbeta\/delta agonist alleviates diabetic osteoporosis via regulating M1\/M2 macrophage polarization","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2025.116115_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.759843","article-title":"Chondroitin sulfate alleviates diabetic osteoporosis and repairs bone microstructure via anti-oxidation, anti-inflammation, and regulating bone metabolism","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.116115_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jare.2024.11.036","article-title":"Asperosaponin VI inhibition of DNMT alleviates GPX4 suppression-mediated osteoblast ferroptosis and diabetic osteoporosis","volume":"75","author":"Wei","year":"2025","journal-title":"J. Adv. Res."},{"issue":"31","key":"10.1016\/j.intimp.2025.116115_bb0045","doi-asserted-by":"crossref","first-page":"28353","DOI":"10.1021\/acsnano.5c06549","article-title":"An Immunomodulating regenerating hydrogel that rescues the oxidative microenvironment and reverses cell senescence for osteoporotic bone defects","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.116115_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40200-016-0275-1","article-title":"Mechanisms involved in altered bone metabolism in diabetes: a narrative review","volume":"15","author":"Ghodsi","year":"2016","journal-title":"J. Diabetes Metab. Disord."},{"issue":"11","key":"10.1016\/j.intimp.2025.116115_bb0055","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-kappaB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.intimp.2025.116115_bb0060","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s12276-023-00980-8","article-title":"Glia maturation factor beta deficiency protects against diabetic osteoporosis by suppressing osteoclast hyperactivity","volume":"55","author":"Shi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.116115_bb0065","doi-asserted-by":"crossref","first-page":"6053410","DOI":"10.1155\/2022\/6053410","article-title":"Combination of calcitriol and Zoledronic acid on PINP and beta-CTX in postoperative patients with diabetic osteoporosis: a randomized controlled trial","volume":"2022","author":"Hu","year":"2022","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.intimp.2025.116115_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00223-023-01112-0","article-title":"Zoledronate promotes Peri-implant osteogenesis in diabetic osteoporosis by the AMPK pathway","volume":"113","author":"Zhang","year":"2023","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.intimp.2025.116115_bb0075","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.2147\/DDDT.S494555","article-title":"Pharmacological mechanisms of Cryptotanshinone: recent advances in cardiovascular, cancer, and neurological disease applications","volume":"18","author":"Zheng","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.intimp.2025.116115_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111332","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ptr.6815","article-title":"Recent advances and future directions in anti-tumor activity of cryptotanshinone: a mechanistic review","volume":"35","author":"Ashrafizadeh","year":"2021","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/mol.107.034447","article-title":"Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase","volume":"72","author":"Kim","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/13880209.2020.1803369","article-title":"Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling","volume":"58","author":"Song","year":"2020","journal-title":"Pharm. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116115_bb0100","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s12276-023-01085-y","article-title":"CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1\/HSP90beta complex","volume":"55","author":"Chen","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.116115_bb0105","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.2147\/DDDT.S328238","article-title":"Oroxin B attenuates Ovariectomy-induced bone loss by suppressing osteoclast formation and activity","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.116115_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122352","article-title":"Bio-orthogonal engineered peptide: a multi-functional strategy for the gene therapy of osteoporotic bone loss","volume":"302","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.116115_bb0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fphar.2019.01344","article-title":"Therapeutic anabolic and Anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis","volume":"10","author":"He","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116115_bb0120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2174\/1389450118666170321105425","article-title":"Therapeutic potential and outlook of alternative medicine for osteoporosis","volume":"18","author":"Wang","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"47","key":"10.1016\/j.intimp.2025.116115_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb7135","article-title":"Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yexcr.2018.09.014","article-title":"L-plastin phosphorylation regulates the early phase of sealing ring formation by actin bundling process in mouse osteoclasts","volume":"372","author":"Chellaiah","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.116115_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"issue":"37","key":"10.1016\/j.intimp.2025.116115_bb0140","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1021\/acs.jafc.4c02982","article-title":"Tetrahydroberberine prevents Ovariectomy-induced bone loss by inhibiting RANKL-induced Osteoclastogenesis and promoting osteoclast apoptosis","volume":"72","author":"Wu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2025.116115_bb0145","doi-asserted-by":"crossref","unstructured":"C. Sobacchi, C. Menale, L. Crisafulli, F. Ficara, Role of RANKL signaling in bone homeostasis, Physiology (Bethesda) 40(1) (2025) 0.","DOI":"10.1152\/physiol.00031.2024"},{"key":"10.1016\/j.intimp.2025.116115_bb0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2025.06.043","article-title":"Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice","volume":"238","author":"Yu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2025.116115_bb0155","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1002\/fsn3.4413","article-title":"Eucommia ulmoides extract regulates oxidative stress to maintain calcium homeostasis and improve diabetic osteoporosis","volume":"12","author":"Shen","year":"2024","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12906-023-04332-x","article-title":"Biochanin a abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS\/MAPK signaling pathway based on integrating molecular docking and experimental validation","volume":"24","author":"He","year":"2024","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"10.1016\/j.intimp.2025.116115_bb0165","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bbrc.2018.10.059","article-title":"Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway","volume":"505","author":"Dong","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2025.116115_bb0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1055\/a-2295-9335","article-title":"Clinical efficacy of bisphosphonates in treating osteoporosis in diabetes patients: a Meta-analysis","volume":"56","author":"Yang","year":"2024","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.116115_bb0175","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-25-0081","article-title":"Effects of metformin and Denosumab on bone and glucose metabolism in postmenopausal women with OP and OA","volume":"266","author":"Jin","year":"2025","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12951-022-01413-w","article-title":"NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.intimp.2025.116115_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040984","article-title":"The sealing zone in osteoclasts: a self-organized structure on the bone","volume":"19","author":"Takito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.116115_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/213492","article-title":"Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer","volume":"2012","author":"Shinomiya","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"14","key":"10.1016\/j.intimp.2025.116115_bb0200","doi-asserted-by":"crossref","first-page":"eabo7868","DOI":"10.1126\/sciadv.abo7868","article-title":"Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2025.116115_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-020-00135-9","article-title":"Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice","volume":"9","author":"Aljohani","year":"2021","journal-title":"Bone Res"},{"issue":"17","key":"10.1016\/j.intimp.2025.116115_bb0210","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1074\/jbc.M115.706937","article-title":"Fascin rigidity and L-plastin flexibility cooperate in Cancer cell Invadopodia and Filopodia","volume":"291","author":"Van Audenhove","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2025.116115_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092432","article-title":"L-Plastin phosphorylation: possible regulation by a TNFR1 signaling Cascade in osteoclasts","volume":"10","author":"Chellaiah","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.intimp.2025.116115_bb0220","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin. Biochem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925021046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925021046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:33:31Z","timestamp":1771511611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925021046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"alternative-id":["S1567576925021046"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116115","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptotanshinone inhibits osteoclast differentiation by targeting LCP1 to suppress diabetic osteoporosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116115"}}